Comprehensive supply chain solutions for the Life Sciences
CryoPortal Login
  • English
    • Español (Spanish)
    • Français (French)
    • 日本語 (Japanese)
    • 简体中文 (Chinese)
Cryoport Systems logo
  • Industry Expertise
    • Cell Therapy
    • Gene Therapy
    • Biologics
    • Support by Development Phase
      • Pre-Clinical Programs
      • Phase I Clinical Programs
      • Phase II Clinical Programs
      • Phase III Clinical Programs
      • Commercial Programs
    • Reproductive Medicine
      • Intended Parents
      • Clinics
    • Animal Health
      • Animal Pharmaceuticals
      • Livestock Management
      • Veterinary Care
  • Trusted Solutions
    • Shipping Systems
      • Cryogenic (below -150°C) Shipping Systems
        • Cryoport Express® Cryogenic Standard Shipping System
        • Cryoport Express® Cryogenic Combo Shipping System
        • Cryoport Express® Cryogenic HV3 Shipping System
        • Cryomax® Cryogenic Shipping System
      • Ultra Cold (-60 to -80°C) Shipping Systems
        • Cryoport Elite® Ultra Cold
      • Refrigerated (2 to 8°C) and CRT (15 to 25°C) Shipping Systems
        • Cryoport Express® C3™ Shipping System
      • Cryoport Accessories
        • Cryoport Safepak® System
    • Transportation
      • Cryoshuttle®
    • BioServices
      • Biostorage Solutions
      • Kit Production
      • Secondary Packaging and Labelling
      • Clinical Sample Management
      • Regulatory & QP Services
    • Consulting Services
      • Shipping Risk Assessment and Shipping Lane Qualification
      • Shipping System and Packaging Performance Qualification
      • Custom Packaging and Accessory Development
    • IntegriCell® Cryopreservation
  • Technology
    • Cryoportal®
    • Veri-Clean®
    • Chain of Compliance®
    • Tec4med
    • Custom Packaging and Accessory Development
  • About Us
    • Our People
    • Management
    • Quality
    • Careers
    • Cryoport’s Family of Companies
  • Resources
    • Events
    • Supply Chain Blog
    • Company News & Articles
    • Brochures and Spec Sheets
    • Instructions
    • White Papers and Case Studies
    • Videos/Webinars
    • Reference Materials
      • Cryoportal® 2 Training Materials
      • Validation Package Request
      • Data Station Direction & Validation
      • Quality Change Notification Request
      • Smartpak II™ Airline Authorizations
  • Contact Us
    • Request a Quote
    • Locations
  • Investor Relations
CryoPortal Login
Request Info
Request a Quote
Request a Quote
Request Info Request a Quote

Animal Health Archives

09/16/2025

Temperature-Controlled Shipping: A Lifeline for Animal Health Companies

For animal health companies, the success of a product is determined long before it reaches the veterinary clinic, farm, or research facility. No matter how innovative a vaccine, biologic, or next-gen therapy may be, its ultimate impact depends on maintaining its integrity during transportation. Temperature-controlled logistics are no longer a back-office concern, they have become a core element of success that impacts product efficacy, regulatory compliance, and even operational efficiency.

Read More

Read More
07/22/2025

What’s Next for the CGT Industry? Mid-Year Check-In from the Leadership Team

We’re halfway through 2025, and the cell and gene therapy (CGT) landscape stands at a crossroads. Innovation continues to advance, yet the infrastructure required to support commercialization remains under pressure. To assess the current state of the industry and what’s ahead, Cryoport Systems gathered candid insights from our internal leaders across functions, from product development and commercial strategy to operations and client engagement.

Read More

Read More
06/28/2025

Celebrating Logistics, the Unsung Hero in Cell and Gene Therapy Innovation

Every National Logistics Day offers a chance to recognize the systems and people that quietly power the innovation engine for Cell and Gene Therapy (CGT). While logistics frequently brings to mind images of trucks and warehouses, cardboard boxes, and tracking numbers, for CGT developers, it’s the infrastructure that protects innovation and ensures that time-sensitive, potentially life-changing treatments reach patients intact and on time.  At Cryoport Systems, logistics has never been just about transportation. It’s about Enabling the Outcome™.

Read More

Read More
06/27/2025

Bridging the Gaps: How Cryoshuttle® Enhances First and Last Mile Resilience

For advanced therapies, the most vulnerable parts of the transportation journey aren’t always the longest. In fact, the greatest risks often occur in the shortest distances. While intercontinental transport and customs clearance are well-known hurdles, both the first and last mile remain highly vulnerable to disruption.  Cryoport Systems developed our Cryoshuttle® local pickup and delivery services to help close the gap between global transport lanes and local handling environments.

Read More

Read More
06/17/2025

Ensuring Safe, On-Time Deliveries for Animal Biopharma

Transporting advanced therapeutics for the animal health industry is just as time- and temperature-sensitive as human therapeutics, yet it is not often managed with the same level of care. This results in biologics and vaccines running into preventable risk during transit. Whether you’re supporting a clinical trial, delivering commercial supply, or responding to a health emergency, ensuring the quality, compliance, and visibility of every shipment is crucial.

Read More

Read More
06/04/2025

Engineering for Impact: A Conversation with Mike Dybicz on the HV3 and Safepak Systems

When it comes to cell and gene therapy (CGT) logistics, innovation is about more than improving efficiency, it’s about safeguarding a patient’s only chance at treatment. We sat down with Mike Dybicz, Senior Vice President & Chief Product Development Officer, to discuss how Cryoport Systems is reshaping the future of CGT logistics with innovative products such as Cryoport Express® Cryogenic HV3 Shipping System and Safepak® System 1800, designed specifically to reduce risk, increase reliability, and ultimately improve patient outcomes. 

Read More

Read More
06/01/2025

Honoring Survivors, Enabling the Future

Each year on the first Sunday in June, National Cancer Survivors Day serves as a powerful reminder that behind every innovation in medicine, every breakthrough treatment, and every clinical milestone, there are human stories of courage, resilience, and hope. At Cryoport Systems, we pause today not only to recognize the strength of cancer survivors but also to reflect on how our work supports the treatments that are changing survival outcomes. 

Read More

Read More
05/29/2025

Starting Smart: How to Structure an Integrated Supply Chain in Early-Stage CGT Programs

For many academic labs, technology spinouts, and early-stage CGT companies, the temperature-controlled supply chain feels like something to figure out later. But when dealing with highly sensitive starting materials and therapies like CGTs, later can quickly become too late. Whether you’re preparing for first-in-human trials or just beginning to plan for scale, integrated thinking now can spare you time, cost, and complexity later.

Read More

Read More
05/20/2025

Why Animal Health Supply Chains Require Uncompromising Quality

Quality failures in animal health logistics do more than delay delivery, they put animal welfare at risk, threaten product efficacy, and erode public trust in veterinary medicine. Today’s biologics and vaccines are often made with temperature-sensitive proteins, viral vectors, or living cells, making the cold chain a essential operational function that directly impacts both clinical outcomes and commercial success.

Read More

Read More
04/16/2025

Delivering Over 5 Billion Doses of Biotherapeutics to Protect Animal Health Worldwide

 In 2024, Cryoport Systems achieved a remarkable milestone: the delivery of over 5 billion doses of biotherapeutics, including cell-based therapies, antibody-based therapies, and vaccines to the global animal health industry. This achievement is the result of our unwavering commitment to ensuring the health and well-being of animals across the world, from livestock that sustain global food supply chains to the beloved companion animals that enrich our lives. 

Read More

Read More
Load More

Categories

  • All (44)
  • Animal Pharmaceuticals (15)
  • Expert Insights (12)
  • Livestock Management (10)
  • Veterinary Support (13)

Tags

  • Animal Genetics
  • Animal Husbandry
  • Animal Reproductive Materials
  • Biologics
  • Biosecurity
  • Cold Chain Management
  • Europe
  • Global Logistics Tracking
  • North America
  • Regenerative Medicine
  • Risk Mitigation
  • Standards and Compliance
  • Supply Chain Management
  • Vaccines

Subscribe to our newsletter

Never miss another update! Join our mailing list for all the latest news, events, and announcements.

  • Clinical Trial icon Trusted with 745 clinical trials
  • Approved therapies icons Supporting 19 approved therapies
  • Quality icon Robust quality standards
  • Client service icon 24/7/365 support team
  • About Us
  • Industries
  • Solutions
  • Resources
  • Technology & Innovation
  • Contact Us
  • About Us
  • Industries
  • Solutions
  • Resources
  • Technology & Innovation
  • Contact Us
Cryoport Systems logo
  • Privacy Policy
  • Terms of Use
  • Careers
Request a Quote
  • youtube
  • twitter
  • linkedin
Cryoport Systems logo

© 2024 Cryoport Systems, LLC. All rights reserved.
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC

  • youtube
  • twitter
  • linkedin